New antibody attacks 99% of HIV strains

Re:New antibody attacks 99% of HIV strains by pkaye on Sunday September 24, 2017 @12:18AM (#15323277)

Given the lower labor costs and people consider drugs to be so profitable, I don't know why other countries don't do as much research and drug development. Just a few countries carry the lion share of this effort.

[ Parent | on HN ]

Re:New antibody attacks 99% of HIV strains by refurb on Sunday September 24, 2017 @12:34AM (#15323324)

That would be my response. If someone else can improve R&D and lower the cost of drugs, they are more than welcome to. Interestingly, I haven't seen any takers.

[ Parent | on HN ]

Re:New antibody attacks 99% of HIV strains by tertius on Sunday September 24, 2017 @03:38PM (#15326137)

This is constantly done... Find some new discoveries in basic science. Get finding. Develop a drug. Test and redevelop. Market. Profit.

[ Parent | on HN ]

Re:New antibody attacks 99% of HIV strains by refurb on Monday September 25, 2017 @12:45AM (#15328127)

Based on lowering the costs of R&D? I've yet to see it.

[ Parent | on HN ]

Re:New antibody attacks 99% of HIV strains by tertius on Thursday September 28, 2017 @09:25AM (#15356913)

Yes, many people bring their work out of academia and have much lower cost of R&D because they don't have to pay for any of the pre-work.

Reagents are getting cheaper and better as well.

Yesteryears low hanging fruit costs the same as today's low hanging fruit. They are harder to solve though.

And no, I'm not saying everyone single biotech startup is like this or every single researcher does this. And yes many fail, but that's the cost of doing business and it's something that makes things progress.

[ Parent | on HN ]

Re:New antibody attacks 99% of HIV strains by tertius on Sunday September 24, 2017 @12:26PM (#15325330)

Drug development is expensive.

[ Parent | on HN ]